Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 6 September 2011
Vol. 4, Issue 189, p. pc17
[DOI: 10.1126/scisignal.2002464]


Science Signaling Podcast: 6 September 2011

Vineet Gupta1 and Annalisa M. VanHook2

1 Division of Nephrology and Hypertension, Department of Medicine, and Department of Biochemistry and Molecular Biology, University of Miami, Miami, FL 33136, USA.
2 Web Editor, Science Signaling, American Association for the Advancement of Science, 1200 New York Avenue, NW, Washington, DC 20005, USA.

Abstract: This Podcast features a conversation with the senior author of a Research Article published in the 6 September 2011 issue of Science Signaling. During the inflammatory response, leukocytes migrate out of circulation and into injured or infected tissues. Although some inflammation is important for healing and fighting infection, chronic inflammation may cause tissue damage and disease. The integrin CD11b/CD18 is required for leukocytes to migrate to sites of injury, but efforts to reduce recruitment by inhibiting signaling through this integrin have not been successful in clinical trials. Vineet Gupta discusses his group’s finding that activating signaling through CD11b/CD18 reduced leukocyte recruitment to sites of injury in mice and may be an effective strategy for developing human therapeutics.

Citation: V. Gupta, A. M. VanHook, Science Signaling Podcast: 6 September 2011. Sci. Signal. 4, pc17 (2011).

Read the Full Text

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882